NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Ben Gil Price$16.9M
Market Cap • 18/04/20242014
(há 10 anos)
2016
(8 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts5
N° de Empregados • 2021Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NRBOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.